Cancer Care Ontario | Cancer Care Ontario

1907 Results

Guidelines and Advice

Consensus Pathology Recommendations for Mesenchymal Tumours of Soft Tissue and Bone

Status: Current
Version: 1.0

Mar 2023

Guidelines and Advice

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Status: Current
ID: GL-C50-21

Jul 2015

Guidelines and Advice

Summary of Recommendations for Primary Care Management after Stem Cell Transplant

Status: Current
Version: 2

Mar 2022

Document

[PDF]

Ontario-Cervical-Screening-Program-Recommendations-for-Cervical-Screening-and-Colposcopy-with-HPV-testing.pdf

Feb 2025

MyPractice Primary Care Plus (with Screening Activity Report data): Frequently Asked Questions

The following information answers many of the questions primary care physicians commonly ask about the MyPractice Primary Care Plus (including...

Guidelines and Advice

Ontario Health (Cancer Care Ontario) Endorsement of ASCO Rapid Recommendation on 177Lutetium-Prostate-Specific Membrane Antigen-617 (PSMA-617) for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Status: Current
ID: GL-END 3-25

Nov 2023

Guidelines and Advice

Recommendations on screening for breast cancer in average-risk women aged 40–74 years

Nov 2011

Guidelines and Advice

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Status: Current

Apr 2021

Statistical Reports

Prevention System Quality Index: Special Report on Cancer Prevention for People Living with Serious Mental Illness

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2023

Status: Current
Version: PET 2023-2

Jun 2024

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Status: Current
ID: PET 2024-1

Mar 2025

Guidelines and Advice

Radionuclide Therapy for Patients with Neuroendocrine Tumors (NETs) in Ontario: Expert Panel Report

Status: Current
ID: GL-C50-01

Jan 2011

Consensus Pathology Recommendations for Mesenchymal Tumours of Soft Tissue and Bone

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Summary of Recommendations for Primary Care Management after Stem Cell Transplant

Ontario-Cervical-Screening-Program-Recommendations-for-Cervical-Screening-and-Colposcopy-with-HPV-testing.pdf

MyPractice Primary Care Plus (with Screening Activity Report data): Frequently Asked Questions

Ontario Health (Cancer Care Ontario) Endorsement of ASCO Rapid Recommendation on 177Lutetium-Prostate-Specific Membrane Antigen-617 (PSMA-617) for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Recommendations on screening for breast cancer in average-risk women aged 40–74 years

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Prevention System Quality Index: Special Report on Cancer Prevention for People Living with Serious Mental Illness

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2023

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Radionuclide Therapy for Patients with Neuroendocrine Tumors (NETs) in Ontario: Expert Panel Report

Pages